BCPEMI
Bain Capital Public Equity Management II Portfolio holdings
AUM
$2.11B
1-Year Return
45.37%
This Quarter Return
+7.18%
1 Year Return
+45.37%
3 Year Return
+213.2%
5 Year Return
+464.26%
10 Year Return
–
AUM
$1.08B
AUM Growth
+$951M
(+767%)
Cap. Flow
+$946M
Cap. Flow
% of AUM
87.96%
Top 10 Holdings %
Top 10 Hldgs %
61.71%
Holding
57
New
39
Increased
2
Reduced
1
Closed
6
Top Buys
| 1 |
DocuSign
DOCU
|
$152M |
| 2 |
PLAN
Anaplan, Inc.
PLAN
|
$93M |
| 3 |
Novartis
NVS
|
$89.9M |
| 4 |
Dayforce
DAY
|
$66.2M |
| 5 |
Crown Holdings
CCK
|
$63.8M |
Top Sells
| 1 |
CSX Corp
CSX
|
$12.6M |
| 2 |
Stanley Black & Decker
SWK
|
$6.01M |
| 3 |
Johnson Controls International
JCI
|
$5.3M |
| 4 |
Honeywell
HON
|
$2.96M |
| 5 |
ATI
ATI
|
$1.52M |
Sector Composition
| 1 | Technology | 42.55% |
| 2 | Consumer Discretionary | 18.57% |
| 3 | Industrials | 14.89% |
| 4 | Healthcare | 13.58% |
| 5 | Financials | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
SPDR S&P 500 ETF Trust
SPY
$660B
| – | – |
0
| – | – |
|
|
52
Stanley Black & Decker
SWK
$11.5B
| – | – |
-44,149
| Closed | -$6.01M |
|
53
Teva Pharmaceuticals
TEVA
$21.3B
| – | – |
0
| – | – |
|
54
SPDR S&P Biotech ETF
XBI
$5.26B
| – | – |
0
| – | – |
|
55
SPDR S&P Retail ETF
XRT
$437M
| – | – |
0
| – | – |
|